Obesity in Central Asia

Introduction[edit]
Obesity, defined as an excessive accumulation of body fat, has become a significant public health issue globally, including in Central Asia. Measured by the Body Mass Index (BMI), with a BMI of 30 or above classified as obesity, it is a condition linked with various health risks such as type 2 diabetes, heart disease, and certain cancers.
Causes of Obesity[edit]
Obesity results from a complex interplay of genetic, environmental, and lifestyle factors. In Central Asia, contributing factors include changes in dietary patterns, reduced physical activity, urbanization, and socioeconomic transitions.
Obesity in Central Asia: An Overview[edit]
Central Asia, comprising several countries with diverse cultures and economic backgrounds, has seen varying levels of obesity prevalence. This rise poses challenges to the region's healthcare systems and public health initiatives.
Ranking of Central Asian Countries by Obesity Rates[edit]
[Insert a list or table here of Central Asian countries ranked by their obesity rates, based on the most recent data available. The list should include countries like Kazakhstan, Uzbekistan, Turkmenistan, Kyrgyzstan, and Tajikistan.]
Health Impact[edit]
In Central Asia, obesity is a contributing factor to the increasing burden of chronic diseases, impacting individuals' health and the healthcare sector's capacity.
Efforts to Combat Obesity[edit]
Efforts to mitigate the obesity epidemic in Central Asia include national public health campaigns, initiatives promoting physical activity and healthy eating, and policy interventions.
Challenges and Future Directions[edit]
Tackling obesity in Central Asia requires addressing the unique challenges of the region, including cultural, economic, and infrastructure considerations. Future strategies will need to integrate culturally sensitive health education, policy reforms, and community engagement.
Obesity by country[edit]
| Country | other name | Obesity rate | Date of information | Ranking | Region |
|---|---|---|---|---|---|
| Russia | Russia | 23.1 | 2016 | 70 | Central Asia |
| Kazakhstan | Kazakhstan | 21 | 2016 | 94 | Central Asia |
| Turkmenistan | Turkmenistan | 18.6 | 2016 | 116 | Central Asia |
| Kyrgyzstan | Kyrgyzstan | 16.6 | 2016 | 122 | Central Asia |
| Uzbekistan | Uzbekistan | 16.6 | 2016 | 123 | Central Asia |
| Tajikistan | Tajikistan | 14.2 | 2016 | 128 | Central Asia |
Conclusion[edit]
Obesity in Central Asia is a growing concern that calls for a multifaceted response involving government actions, health education, and community participation. Emphasizing preventive measures and effective management strategies is key to curbing the obesity trend in the region.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian